References
- Callen JP. Neutrophilic dermatosis. Dermatol Clin 2002; 20: 409–19
- Su WP, Fett DL, Gibson LE, Pittelkow MR. Sweet syndrome: acute febrile neutrophilic dermatosis. Semin Dermatol 1995; 14: 173–8
- Jeanfils S, Joly P, Young P, Le Corvuisier-Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol 1997; 36: 436–9
- Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985; 80: 615–20
- Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173–86
- Gallo R, Parodi A, Rebora A. Pyoderma gangrenosum in a patient with gastric carcinoma. Int J Dermatol 1995; 34: 713–4
- Cailhol J, Viard JP, Dupont B, Aaron L. Cutaneous and extracutaneous pyoderma gangrenosum associated with sigmoid adenocarcinoma. Gastroenterol Clin Biol 2003; 27: 955–7
- De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938–47
- Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am 1989; 73: 1247–61
- Galun E, Flugelman MY, Rachmilewitz D. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986; 81: 988–9
- Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002; 3: 149–58
- Curley RK, MacParlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporine. Br J Dermatol 1985; 113: 601–4
- Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1821–6
- Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellstrom PM. Pyoderma gangrenosum associated with Crohn disease: effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol 2002; 37: 1108–10